WHO: Cancer Survival Gap Widens Between Rich and Poor Nations
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- WHO report documented 'persistent and widening' inequities in cancer prevention, diagnosis, treatment and care, with an estimated 20.6 million cases and 10 million deaths annually projected to reach nearly 35 million cases by 2050
- Survival rates for breast and childhood cancers diverge sharply: 85% of patients in richer countries survive at least five years, compared with under 30% in poorer countries
- Cancer drug access is severely limited in low- and lower-middle income countries, where only 9%–54% of the WHO's top-20 priority cancer drugs are available, versus 68%–94% in high-income countries
- Radiation infrastructure is absent in 23 countries entirely, while two-thirds of nations do not include cancer in universal health coverage and up to 90% of patients abandon treatment in some settings due to cost
- Abigail Simon-Hart, a Nigerian breast cancer survivor and patient advocate, told the WHO she has met women who chose death over life-saving mastectomies because of stigma, and parents forced to choose between treatment and keeping a child in school
- IARC deputy head Dr Isabelle Soerjomataram highlighted that four in 10 new cancer cases are linked to known, addressable risk factors including tobacco, infections, alcohol and excess body weight
- Dr Andre Ilbawi, WHO cancer control lead, called on governments and the global community to 'value care as highly as cure' and fund the full continuum from prevention through treatment
Why it matters: The report reframes cancer from a story of scientific triumph to one of structural failure: while treatments exist, 23 countries lack radiation facilities entirely and treatment abandonment hits 90% in some poor settings, meaning billions in research progress translates to zero benefit for the world's most vulnerable patients unless governments fund prevention-to-treatment pipelines.
